Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pivot Pharmaceuticals Inc. PVOTF

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Focusing On Innovative Drug Delivery Technologies

Posted on June 26, 2018 by MissionIR

Pivot offers unique proprietary drug delivery platform technologies Company has a strong intellectual property (IP) portfolio for the formulation and delivery of cannabinoids Company acquires licensing rights to patented Trivair™ nasal and pulmonary drug delivery system, also signs exclusive manufacturing … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Rolling Forward with Cannabis Production Facility

Posted on June 25, 2018 by MissionIR

Facility in Costa Mesa, California, will enable full range of cannabis distribution services Powdered cannabis CBD and THC formulations for beverage alternatives expected to drive multi-billion-dollar market Pivot Pharmaceuticals expects to have licensing to begin manufacturing by July, with equipment … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc.’s (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Advanced Technologies Drive Product Development

Posted on June 8, 2018 by MissionIR

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is an emergent biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that deliver innovative treatments for unmet healthcare needs. An article discussing the company reads: “The advent … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Inks Option Agreement to Acquire Licensing Rights to TriVair™ Drug Delivery System

Posted on May 31, 2018 by MissionIR

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has signed an option agreement with IP Med Inc. to obtain an exclusive worldwide license for Trivair™ Nasal and Pulmonary Breath-Propelled Drug Delivery Systems™ for the … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Inks Manufacturing Agreement with Bio V Pharma Inc.

Posted on May 30, 2018 by MissionIR

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has signed an exclusive contract manufacturing agreement with Bio V Pharma Inc. (“BioV”). Per the agreement, BioV, a Quebec-based full-service manufacturer of pharmaceutical and nutraceutical products, … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Targeting Growing CBD Pet Market with New Product Line

Posted on May 25, 2018 by MissionIR

Company’s new products are designed to address issues such as inflammation, joint pain, post-surgery pain and skin disorders in pets CBD pet market is heating up, with a growing number of cannabis companies already manufacturing products for this niche Pet … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Subsidiary Secures Manufacturing Facility in California

Posted on May 23, 2018 by MissionIR

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned U.S. subsidiary, Pivot Naturals LLC, (“PNL”), has entered a lease agreement for a manufacturing facility in Costa Mesa, California’s Measure “X” Zone. PNL will immediately … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) to Develop Additives and Formulations for Cannabis Beverage Market

Posted on May 22, 2018 by MissionIR

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has initiated development of CBD and THC additives and formulations for the multi-billion dollar beverage industry using its patented Ready-To-Infuse-Cannabis (“RTIC”) Powder and … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Fast-tracks Development for CBD Pet Product Line

Posted on May 18, 2018 by MissionIR

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has accelerated development of several cannabidiol (“CBD”) products for the domestic pet food market. Pivot’s pet product line will be marketed under the … Continue reading →

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Cements Its Position in the Expanding Cannabis Industry

Posted on May 17, 2018 by MissionIR

Global patents for innovative formulations and drug delivery platforms Strong development pipeline for cannabinoid-based pharmaceutical and nutraceutical products Capabilities to manufacture products of a quality unmatched by other industry players Canadian biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) … Continue reading →

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment